News and Events

Get all the latest information on upcoming events, press releases, and other news about CPL here

News

CPL WELCOMES CAMERON CARVALHO AS VICE PRESIDENT, GROWTH

CPL is excited to introduce Cameron Carvalho as our new Vice President, Growth. Cameron brings over 22 years of experience in finance, private equity and pharma having worked for generic, innovative and drug development companies. These companies have included CIBC World Markets, the Canada Pension Plan Investment Board, Teva Canada, Purdue Pharma Canada and most […]

News

CPL’s Senior Manager of Formulations, Chetan Chure, in Pharmaceutical Technology Magazine

Chetan Chure was interviewed for the May 2022 issue of Pharmaceutical Technology Magazine for an article named Topical Formulations in Pharma-Balancing Form and Function regarding approaches and challenges to topical product manufacturing. To read the article, please go to: https://www.pharmtech.com/view/topical-formulations-in-pharma-balancing-form-and-function

News

CPL appoints Mallika Tushakiran as Director, Formulations

CPL is pleased to announce the promotion of Mallika Tushakiran to the position of Director, Formulations. Mallika joined CPL in 2012 as a Principal Scientist, Formulations and has held the position of Associate Director, Formulations since 2017. Cumulatively, Mallika has 30+ years of experience in product development of pharmaceutical dosage forms. This promotion acknowledges the […]

Resources

CPL SHARES EXPERTISE ON in vitro RELEASE AND in vitro PERMEATION TESTING

Sujata Syam, Ph.D. possesses over twenty years’ experience in the fields of Proteins, Assay Development and Therapeutics. Sujata joined CPL in 2015 as head of the Skin Lab and has been leading a group of scientists in developing topical testing techniques such as IVRT, IVPT, and skin-model-based testing. In the attached webinar (see below), Sujata […]

News

CPL Board Chair Caitlin Wege Profiled in DCAT’s Women Leaders in Pharma Interview Series

Caitlin Wege recently was interviewed by DCAT as part of their Women Leaders in Pharmaceutical Interview Series. Caitlin is Board Chair of CPL and its sister subsidiary, Glasshouse Pharmaceuticals. She is also a partner at MooDoos Investments, a private family-owned investment fund that invests in early-stage companies throughout the US and Canada. Caitlin is an […]

News

CPL appoints Brian Lankadurai as Director, Product Development Services

At CPL, our goal is to be the very best topical and non-sterile liquid CDMO in the world.  In order to be the best, we have built an experienced team of experts that can guide our customers’ products through the development, scale-up, and commercial manufacturing stages.  We are proud of our team and want to […]

Events

Dermatology Drug Development Summit-2021

CPL will be attending the Dermatology Drug Development Summit, sponsored by Hanson Wade, in Boston, Massachusetts, November 17th and 18th.  Many of the leading dermatology drug companies will be attending this exciting two day summit to share perspectives, insights, and information on the current issues surrounding the development of new dermatology therapeutics.  CPL will have a […]

Events

CPhI 2021

CPL will be exhibiting at the CPhI North America conference. Please visit us at Booth 1148 in Philadelphia, PA August 10-12, 2021. For more information on the event, visit CPhI.

Resources

CPL shares expertise on topical semi-solid product development with Critical Process Parameter studies

As the skin is the largest organ in the human body, it presents a potential target for a number of pharmaceutical compounds intended to treat a variety of diseases and conditions. There are multiple different layers to target, several drug penetration routes, and a variety of topically-delivered product formulations-creams, ointments, gels, and lotions—to choose from […]

Resources

Contract Pharmaceuticals Limited, the one-stop shop for innovation

Growing pressure in the pharmaceutical industry for quicker delivery times for products to reach market, while at the same time reducing costs, is leading an increasing number of companies to outsource a range of product activities to third parties, from development through to commercialisation. And with an array of available partners specialising in each of […]